Glaxosmithkline Pharmaceuticals standalone net profit declines 22.67% in the September 2018 quarter

Sales decline 2.39% to Rs 816.31 crore

Net profit of Glaxosmithkline Pharmaceuticals declined 22.67% to Rs 100.77 crore in the quarter ended September 2018 as against Rs 130.32 crore during the previous quarter ended September 2017. Sales declined 2.39% to Rs 816.31 crore in the quarter ended September 2018 as against Rs 836.26 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales816.31836.26 -2 OPM %20.2322.97 -PBDT179.76201.70 -11 PBT168.25193.97 -13 NP100.77130.32 -23

Powered by Capital Market - Live News